Catalyst Wire Dossier Catalyst Wire Dossier

0.005% estriol vaginal gel

estriol · ITF Research Pharma, S.L.U.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.005% estriol vaginal gel, covering 2019-08-05 to 2019-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting [Phase 2]

See pricing